Thus, stiffness-E2F3 axis induced FGF2 release promoted HCC cell growth through FGFR1-mediated PI3K/AKT and MEK1/2/ERK1/2 pathway activation. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.